Aligos Therapeutics, Inc. · NASDAQ:ALGS

Woodline Partners LP reported a 5.40% stake in Aligos Therapeutics, Inc. (Schedule 13G/A)

Event Dec 31, 2025 · Filed Feb 17, 2026

Woodline Partners LP reported a 5.40% stake in Aligos Therapeutics, Inc., 289,169 shares, as a passive investor on Dec 31, 2025. Filed Feb 17, 2026 (Schedule 13G/A).

Stake
5.40%
Shares
289,169
Intent
Passive
What changed
Stake changed

The filing in full

HolderStakeShares
Woodline Partners LP5.40%289,169

Source

View original at SEC

Related